An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military
1 other identifier
interventional
34
1 country
2
Brief Summary
It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program. The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 3, 2017
CompletedFirst Posted
Study publicly available on registry
November 9, 2017
CompletedStudy Start
First participant enrolled
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2020
CompletedFebruary 19, 2020
February 1, 2020
1.1 years
November 3, 2017
February 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PTSD CheckList-5 (PCL-5)
A 20-item self-report measure of PTSD symptoms as defined by the DSM-5. Higher scores indicate greater PTSD symptom severity.
Change from baseline to 1-month follow-up (post-treatment)
Secondary Outcomes (1)
Patient Health Questionnaire-9 (PHQ-9)
Change from baseline to 1-month follow-up (post-treatment)
Study Arms (1)
Web-PE
EXPERIMENTALTen 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).
Interventions
Ten 60-minute psychotherapy sessions over 8 weeks, focused on gradually confronting distressing trauma-related memories and reminders. Web-PE is an internet-based version of prolonged exposure (PE) for posttraumatic stress disorder (PTSD).
Eligibility Criteria
You may qualify if:
- Active-duty military personnel and veterans who have deployed post 9/11
- Seeking treatment for PTSD
- Significant PTSD symptoms as determined by a PCL-5 score greater than or equal to 31
- Has experienced a Criterion A event that is a specific combat-related event or high magnitude operational experience that occurred during a period of recent military deployment
- Able to speak and read English and access to an internet-connected computer
- Indication that the participant plans to be able to participant in the study for the next three months following the first assessment
You may not qualify if:
- Diagnosis of bipolar disorder or psychotic disorder, as determined by participant self-report)
- Current substance dependence, as determined by participant self-report)
- Diagnosis of a moderate or severe traumatic brain injury, as determined by participant self-report)
- Current suicidal ideation severe enough to warrant immediate attention, as determined by participant self-report)
- Currently engaged in evidence-based treatment for PTSD (e.g. Prolonged Exposure Therapy or Cognitive Processing Therapy), as determined by participant self-report.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- University of Texascollaborator
- VA Palo Alto Health Care Systemcollaborator
Study Sites (2)
Center for the Treatment and Study of Anxiety, University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Assistant Professor
Study Record Dates
First Submitted
November 3, 2017
First Posted
November 9, 2017
Study Start
February 12, 2018
Primary Completion
March 27, 2019
Study Completion
February 14, 2020
Last Updated
February 19, 2020
Record last verified: 2020-02